This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top 5 Picks From S&P 500's Best Sector in the Past Month
by Nalak Das
We have narrowed down our search to five large-cap insurers that have strong growth potential for the rest of 2021. These are: AFL, AIG, MMC, MET and CINF.
Reasons That Make the Stock of MetLife (MET) Attractive Now
by Zacks Equity Research
Economic growth, receding COVID woes, strategic initiatives, balance sheet strength and a consistent dividend payment history make MetLife (MET) a good stock pick.
7 Low Price-to-Sales Stocks to Replenish Your Portfolio
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like HIBB, BSET, NUS, MET, MT, KBH, and SMP are promising picks.
Aflac (AFL) Hits 52-Week High: More Upside Potential Left?
by Zacks Equity Research
Aflac's (AFL) numerous growth strategies, solid investment income and a strong dividend history place it on the long-term growth path.
MET or PUK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MET vs. PUK: Which Stock Is the Better Value Option?
Radian Group (RDN) Ups Share Buyback Authorization by $200M
by Zacks Equity Research
A strong capital position helps Radian Group (RDN) deploy capital via share repurchases and dividend hikes that enhance shareholder value.
3 Insurance Stocks Worth Betting on Now for Solid Gains
by Sapna Bagaria
These insurance stocks are set to gain from a strengthening economy and higher insurance premium rates.
Insurance ETFs Gain on Solid Q2 Earnings
by Sweta Killa
Performance of the insurance industry has been strong this reporting cycle, with the leading players posting robust earnings.
Are You Looking for a High-Growth Dividend Stock? MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
American International (AIG) Q2 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
American International's (AIG) second-quarter results reflect revenue growth, sound General Insurance underwriting results and reduced catastrophe losses, partly offset by high costs.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) Q2 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
MetLife's (MET) second-quarter results reflect growth in top line, improved variable investment income, and well-performing U.S. and Asia segments, partly offset by high expenses.
MetLife (MET) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 47.20% and -0.24%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: PetroChina, AdvanSix, ArcBest, MetLife and Haverty Furniture
by Zacks Equity Research
Zacks.com featured highlights include: PetroChina, AdvanSix, ArcBest, MetLife and Haverty Furniture
Zacks.com featured highlights include: Bassett Furniture, Foot Locker, Signet Jewelers, MetLife, ArcelorMittal, Schneider National and Vishay Intertechnology
by Zacks Equity Research
Zacks.com featured highlights include: Bassett Furniture, Foot Locker, Signet Jewelers, MetLife, ArcelorMittal, Schneider National and Vishay Intertechnology
Buy These 7 Low Price-to-Sales Stocks for Standout Returns
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like BSET, FL, SIG, MET, MT, SNDR and VSH are promising picks.
Tap These 5 Bargain Stocks With Exciting EV-to-EBITDA Ratios
by Anindya Barman
We have screened bargain stocks PTR, ASIX, ARCB, MET and HVT based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
MetLife (MET) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for MetLife's (MET) Earnings in Q2?
by Zacks Equity Research
MetLife's (MET) Q2 results are likely to reflect growth in both earnings and revenues.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Lincoln National (LNC) Boosts Suite With In-Plan Income Solution
by Zacks Equity Research
Lincoln National (LNC) launches an in-plan protected income solution aimed at offering secured monthly income to customers with target-date portfolios.
Zacks Industry Outlook Highlights: MetLife, American International Group, Cigna, Prudential Financial and Horace Mann Educators Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: MetLife, American International Group, Cigna, Prudential Financial and Horace Mann Educators Corp
7 Multiline Insurers to Watch Out For as Economic Recovery Gains Traction
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, CI, HIG, PRU, AIZ and HMN as the impact of the pandemic recedes.
Why the Earnings Surprise Streak Could Continue for MetLife (MET)
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Multiline Insurers Well Poised to Beat Q2 Earnings Estimates
by Debasmita Chatterjee
Better pricing environment, reduced catastrophe losses and improved underwriting results, are likely to aid MET, AIG, AIZ and LMND in outpacing Q2 earnings estimates.